rethinkPeptides Search
Menu
Research citation

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.

Obstetrics and gynecology, 134(5), 899-908

Citation

Kingsberg, Sheryl A; Clayton, Anita H; Portman, David; Williams, Laura A; Krop, Julie; Jordan, Robert; Lucas, Johna; Simon, James A. (2019). Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.. Obstetrics and gynecology, 134(5), 899-908. https://doi.org/10.1097/AOG.0000000000003500